• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4610651)   Today's Articles (135)   Subscriber (49380)
For: Greenspon AJ. A review of oral anticoagulants in patients with atrial fibrillation. Postgrad Med 2013;124:7-16. [PMID: 23322134 DOI: 10.3810/pgm.2012.11.2608] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Number Cited by Other Article(s)
1
Arora P, Muehrcke M, Russell M, Jayasekare R. Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants. J Comp Eff Res 2022;11:1105-1120. [PMID: 36065839 DOI: 10.2217/cer-2021-0307] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]  Open
2
Sitticharoenchai P, Takkavatakarn K, Boonyaratavej S, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. Non-Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non-Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis. J Am Heart Assoc 2021;10:e019609. [PMID: 33728927 PMCID: PMC8174352 DOI: 10.1161/jaha.120.019609] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
3
Glikson E. In response to Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents. Laryngoscope 2019;129:E161. [PMID: 30724345 DOI: 10.1002/lary.27817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2018] [Accepted: 12/31/2018] [Indexed: 11/09/2022]
4
Glikson E, Chavkin U, Madgar O, Sagiv D, Nakache G, Yakirevitch A, Wolf M, Alon EE. Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents. Laryngoscope 2018;129:119-123. [DOI: 10.1002/lary.27400] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/30/2018] [Indexed: 11/08/2022]
5
Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation. Eur J Clin Pharmacol 2018;74:1061-1070. [DOI: 10.1007/s00228-018-2467-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Accepted: 04/23/2018] [Indexed: 02/01/2023]
6
Dager WE, Banares L. Reversing the anticoagulation effects of dabigatran. Hosp Pract (1995) 2017;45:29-38. [PMID: 28335637 DOI: 10.1080/21548331.2017.1298389] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
7
Fastner C, Behnes M, Sartorius B, Yildiz M, Mashayekhi K, El-Battrawy I, Lehmann R, Baumann S, Becher T, Borggrefe M, Akin I. Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study. BMC Cardiovasc Disord 2016;16:25. [PMID: 26822890 PMCID: PMC4730589 DOI: 10.1186/s12872-016-0200-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2015] [Accepted: 01/22/2016] [Indexed: 01/29/2023]  Open
8
Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation. Am J Ther 2015;22:248-56. [DOI: 10.1097/mjt.0000000000000001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
9
GAFOOR SAMEER, FRANKE JENNIFER, BOEHM PATRICK, LAM SIMON, BERTOG STEFAN, VASKELYTE LAURA, HOFMANN ILONA, SIEVERT HORST. Leaving No Hole Unclosed: Left Atrial Appendage Occlusion in Patients Having Closure of Patent Foramen Ovale or Atrial Septal Defect. J Interv Cardiol 2014;27:414-22. [DOI: 10.1111/joic.12138] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]  Open
10
Mitrousi K, Lip GYH, Apostolakis S. Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants. J Atr Fibrillation 2013;6:783. [PMID: 28496851 DOI: 10.4022/jafib.783] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2012] [Revised: 04/25/2013] [Accepted: 04/26/2013] [Indexed: 02/02/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA